Published Date: 08 Mar 2023
Every year, tap burns in the United States come at a high personal and financial cost, according to an analysis of nationally significant data published online in the Journal Injury Prevention.
Read Full NewsAbout one third of cancers detected by PSA screening at age 70, and more than half at age 80, are unlikely to become clinically meaningful within 15 years.
A ‘target trial’ emulation study suggests that regular exercise can help breast cancer survivors live longer.
Broader implementation would require substantial investment, but long-term dividends of liquid biopsy analysis in the region could affect diagnosis and care of much more than just this cancer.
Counterintuitive findings hint that diets rich in fruit, vegetables, and whole grains may increase the risk of lung cancer in young nonsmokers, but experts are skeptical.
Photopenia in high CT density renal lesions on [18F]FDG PET/CT scans shows a high negative predictive value for excluding malignancy.
A phase 2 study investigates the combination of cladribine plus low-dose cytarabine and venetoclax alternating with azacitidine plus venetoclax for newly diagnosed acute myeloid leukemia.
Approval was based on findings from the phase 3 VERITAC-2 trial showing significantly improved PFS for patients with ESR1-mutated disease.
1.
Talk About Medication Costs, Bringing Back Touch, and Understanding From Dish Tumors.
2.
Acupuncture may alleviate nocturia in men treated for prostate cancer
3.
improvements in the treatment of prostate cancer resistant to chemotherapy.
4.
After three years, responses to mounetuzumab in follicular lymphoma are still stable.
5.
New BCMA-Directed Therapies Show Promise in Multiple Myeloma
1.
Liquid Biopsy: A Revolutionary Tool for Early Detection and Monitoring of Colorectal Cancer
2.
Neoadjuvant Abraxane Chemotherapy Combined with Neutrophil Cytopharmaceuticals and Radiotherapy
3.
Unleashing Precision Medicine: CRISPR-Cas9 Gene Editing in Hematopoietic Stem Cells
4.
Clinical Analysis of Prostate Cancer
5.
Understanding Blood Dyscrasia: Symptoms, Causes and Treatment Options
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part II
2.
Efficient Management of First line ALK-rearranged NSCLC
3.
The Era of Targeted Therapies for ALK+ NSCLC: A Paradigm Shift
4.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VII
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation